FERMENTA BIOTECH Quarterly Results
| Consolidated | Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 Audited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹137 Cr | ₹130 Cr | ₹136 Cr | ₹140 Cr | ₹156 Cr | ₹95 Cr | ₹78 Cr | ₹97 Cr |
| Expenses | ₹112 Cr | ₹104 Cr | ₹108 Cr | ₹103 Cr | ₹103 Cr | ₹76 Cr | ₹77 Cr | ₹92 Cr |
| Operating Income | ₹25 Cr | ₹27 Cr | ₹28 Cr | ₹37 Cr | ₹53 Cr | ₹19 Cr | ₹1 Cr | ₹5 Cr |
| Other Income | ₹3 Cr | ₹5 Cr | ₹9 Cr | ₹4 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹5 Cr |
| Interest | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr |
| Depreciation | ₹5 Cr | ₹5 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr |
| Profit Before Tax | ₹17 Cr | ₹24 Cr | ₹28 Cr | ₹32 Cr | ₹45 Cr | ₹12 Cr | ₹-6 Cr | ₹1 Cr |
| Profit After Tax | ₹12 Cr | ₹18 Cr | ₹22 Cr | ₹33 Cr | ₹38 Cr | ₹11 Cr | ₹-6 Cr | ₹-7 Cr |
| EPS | ₹4.39 | ₹6.49 | ₹7.49 | ₹11.79 | ₹12.66 | ₹3.92 | ₹-2.01 | ₹-2.40 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| FERMENTA BIOTECH | -0.2% | -0.5% | 7% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.5% | 5.5% | 0.5% |
| DIVIS LABORATORIES | 2.3% | 3.6% | 7.8% |
| CIPLA | -1.1% | -2.2% | -8.9% |
| TORRENT PHARMACEUTICALS | -0.5% | 5.3% | 40.2% |
| DR REDDYS LABORATORIES | 0.9% | 5.2% | 7% |
| MANKIND PHARMA | -2.6% | -5.6% | -15% |
| ZYDUS LIFESCIENCES | -1% | 1.8% | 0.1% |
| LUPIN | -0% | 2.5% | 13.2% |
FERMENTA BIOTECH Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 5.48 % |
| Y-o-Y | -12.21 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Dec2025 | ₹137 Cr | 5.48 | |
| Sep2025 | ₹130 Cr | -4.43 | |
| Jun2025 | ₹136 Cr | -2.56 | |
| Mar2025 | ₹140 Cr | -10.62 | |
| Dec2024 | ₹156 Cr | 64.66 | |
| Sep2024 | ₹95 Cr | 21.62 | |
| Jun2024 | ₹78 Cr | -19.73 | |
| Mar2024 | ₹97 Cr | - | |
FERMENTA BIOTECH Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | -6.27 % |
| Y-o-Y | -53.14 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Dec2025 | ₹25 Cr | -6.27 | |
| Sep2025 | ₹27 Cr | -5.66 | |
| Jun2025 | ₹28 Cr | -23.58 | |
| Mar2025 | ₹37 Cr | -30.65 | |
| Dec2024 | ₹53 Cr | 183.64 | |
| Sep2024 | ₹19 Cr | 2,235.95 | |
| Jun2024 | ₹1 Cr | -85.04 | |
| Mar2024 | ₹5 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -11.15 % |
| Y-o-Y | -46.64 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Dec2025 | 18.17% | -11.15 | |
| Sep2025 | 20.45% | -1.30 | |
| Jun2025 | 20.72% | -21.57 | |
| Mar2025 | 26.42% | -22.41 | |
| Dec2024 | 34.05% | 72.32 | |
| Sep2024 | 19.76% | 1,818.45 | |
| Jun2024 | 1.03% | -81.34 | |
| Mar2024 | 5.52% | - | |
FERMENTA BIOTECH Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | -33.31 % |
| Y-o-Y | -68.27 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Dec2025 | ₹12 Cr | -33.31 | |
| Sep2025 | ₹18 Cr | -16.54 | |
| Jun2025 | ₹22 Cr | -35.18 | |
| Mar2025 | ₹33 Cr | -12.05 | |
| Dec2024 | ₹38 Cr | 240.67 | |
| Sep2024 | ₹11 Cr | Positive | |
| Jun2024 | ₹-6 Cr | Negative | |
| Mar2024 | ₹-7 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -36.82 % |
| Y-o-Y | -63.86 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Dec2025 | 8.75 % | -36.82 | |
| Sep2025 | 13.85 % | -12.62 | |
| Jun2025 | 15.85 % | -33.49 | |
| Mar2025 | 23.83 % | -1.57 | |
| Dec2024 | 24.21 % | 106.92 | |
| Sep2024 | 11.7 % | Positive | |
| Jun2024 | -7.59 % | Negative | |
| Mar2024 | -7.34 % | - | |
FERMENTA BIOTECH Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | -32.36 % |
| Y-o-Y | -65.32 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Dec2025 | ₹4.39 | -32.36 | |
| Sep2025 | ₹6.49 | -13.35 | |
| Jun2025 | ₹7.49 | -36.47 | |
| Mar2025 | ₹11.79 | -6.87 | |
| Dec2024 | ₹12.66 | 222.96 | |
| Sep2024 | ₹3.92 | Positive | |
| Jun2024 | ₹-2.01 | Negative | |
| Mar2024 | ₹-2.4 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD